Literature DB >> 1482369

Proteolytic activation of a single-chain precursor of hepatocyte growth factor by extracellular serine-protease.

K Mizuno1, T Takehara, T Nakamura.   

Abstract

Hepatocyte growth factor (HGF) is biosynthesized as a single-chain precursor (pro-HGF) and is proteolytically processed to a two-chain mature form. When MRC-5 fibroblasts were pulse-radiolabeled under serum-free conditions, pro-HGF was the predominant molecular form of HGF in the culture medium. CHO cells transfected with an expression plasmid containing a full-size human HGF cDNA produced pro-HGF when these cells were cultured in serum-free medium. These findings suggest that HGF is secreted as a pro-form, which is then converted to a two-chain form by extracellular protease. Single-chain HGF exhibited mitogenic activity on cultured hepatocytes, with a potency similar to that of mature HGF, but this activity was remarkably inhibited by leupeptin. We postulate that inactive pro-HGF is converted to an active two-chain form by a leupeptin-sensitive serine-protease expressed by hepatocytes. Neither plasminogen activators nor plasmin showed any processing activity of pro-HGF in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1482369     DOI: 10.1016/0006-291x(92)90264-l

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Identification of mannose receptor as receptor for hepatocyte growth factor β-chain: novel ligand-receptor pathway for enhancing macrophage phagocytosis.

Authors:  Hiroyuki Ohnishi; Kiyomasa Oka; Shinya Mizuno; Toshikazu Nakamura
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

2.  The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.

Authors:  Kristy A Bauman; Scott H Wettlaufer; Katsuhide Okunishi; Kevin M Vannella; Joshua S Stoolman; Steven K Huang; Anthony J Courey; Eric S White; Cory M Hogaboam; Richard H Simon; Galen B Toews; Thomas H Sisson; Bethany B Moore; Marc Peters-Golden
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 3.  Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis.

Authors:  M Jeffers; S Rong; G F Vande Woude
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

4.  Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.

Authors:  Wendy M Mars; Minji Jo; Steven L Gonias
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

5.  Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Authors:  Junwei Yang; Ryan W Shultz; Wendy M Mars; Rodney E Wegner; Yingjian Li; Chunsun Dai; Kari Nejak; Youhua Liu
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 6.  Hepatocyte growth factor/scatter factor-induced intracellular signalling.

Authors:  K A Stuart; S M Riordan; S Lidder; L Crostella; R Williams; G G Skouteris
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

7.  Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.

Authors:  Hiroto Matsuoka; Thomas H Sisson; Teruaki Nishiuma; Richard H Simon
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-13       Impact factor: 6.914

8.  Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver.

Authors:  M L Liu; W M Mars; R Zarnegar; G K Michalopoulos
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

Review 9.  Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.

Authors:  Hiroshi Itoh; Hiroaki Kataoka
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

10.  An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice.

Authors:  Massimiliano Mazzone; Cristina Basilico; Silvia Cavassa; Selma Pennacchietti; Mauro Risio; Luigi Naldini; Paolo M Comoglio; Paolo Michieli
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.